Keyphrases
18F-FDG PET-CT
100%
Aggressive B-cell Lymphoma
75%
Aggressive non-Hodgkin Lymphoma
100%
Bulky Disease
25%
Clinical Outcome Prediction
100%
Complete Response
25%
Disease-free Survival
75%
End of Therapy
75%
Ethics Boards
25%
Feature Extracting
25%
First-line Therapy
25%
Institutional Ethics
25%
Kurtosis
25%
Large Cohort
25%
Lymphoma Staging
25%
Metabolic Tumor Parameters
100%
Metabolic Tumor Volume
75%
Overall Survival
75%
Parameter Characteristics
100%
Positron Emission Tomography-computed Tomography (PET-CT)
25%
Radiomics
100%
Residual Mass
50%
Response Predictors
25%
Response to Therapy
100%
Texture Features
50%
Therapy Response
50%
Treatment Response
25%
Treatment Survival
100%
Tumor
75%
Tumor Site
25%
Medicine and Dentistry
B-Cell Lymphoma
33%
Disease Free Survival
33%
Diseases
11%
Fluorodeoxyglucose F 18
100%
Neoplasm
100%
Non-Hodgkin Lymphoma
100%
Overall Survival
33%
Polyethylene Terephthalate
22%
Positron Emission Tomography-Computed Tomography
100%
Prognostication
11%
Radiomics
100%
Retrospective Study
11%
Treatment Response
33%
Pharmacology, Toxicology and Pharmaceutical Science
B Cell Lymphoma
33%
Disease Free Survival
33%
Diseases
11%
Fluorodeoxyglucose F 18
100%
Neoplasm
100%
Nonhodgkin Lymphoma
100%
Overall Survival
33%
Polyethylene Terephthalate
100%
Retrospective Study
11%